- LATEST
- WEBSTORY
- TRENDING
HEALTH
Massive breakthrough as rectal cancer disappears in every patient in drug trial
Patients took Dostarlimab every three weeks for six months, and in the end, every one of them saw their tumours disappear.
Updated : Jun 07, 2022, 07:13 PM IST | Edited by : Prashant Tamta
 "Massive breakthrough as cancer disappears in every patient in drug trial")
TRENDING NOW
)
Meet Noel Tata's daughter-in-law who is leading Toyota Kirloskar Group, Ratan Tata was her..., her name is...
)
Meet man who defeated Elon Musk to build world's largest..., Warren Buffett invested in his business, his net worth is...
)
Sara Tendulkar opens up on her marriage plans, here's what she says in this viral reel
)
Not Phil Salt or Bhuvneshwar Kumar, this player is RCB's 'most important pick' in mega auction: Head coach
)
Remember Pratibha Sinha, known for song Pardesi Pardesi? Here's how she looks now
)
Step inside Rekha's Rs 100 crore house Basera, sea-facing bungalow sandwiched between Salman Khan's Galaxy, Shah Rukh Khan's Mannat: See pics
)
Meet Minahil Malik, Pakistani influencer who is going viral after Sajal Malik's alleged private video leak, here's why
)
Meet actor who became star at 15, gave blockbusters with Karisma, challenged Govinda, but one accident ruined his life; he is now...
)
Indian-Canadian couple's dream wedding in Bengaluru turns tragic as colour bomb explodes on bride's back, watch viral video
)
Meet student who secured AIR 99 in JEE Advanced, still did not join IIT, dropped out of counselling for..., he is now..
)
Who owns Vande Bharat, Shatabdi Express coaches? Not Indian Railways, their real owners are...
)
This film, made in Rs 100 crore, was rejected by Rani Mukerji, Deepika Padukone, had no lead hero, still became superhit, was shot only at night due to..., earned Rs..
)
Pony ride operator detained in J&K after tourist accuses him of asking about religion in viral video
)
Good news! 48 students of this IIT college get Rs 60 lakh salary package, not IIT Delhi, IIT Bombay
)
This university, once renowned as 'IAS factory', reclaims its crown with UPSC topper Shakti Dubey's success, not in Delhi, Mumbai, Patna, it is in...
Scientists gained a major breakthrough in the fight against rectal cancer as a new drug has been found to have a 100 per cent success rate in treating the disease.
According to a New York Times report, 18 patients took a drug called Dostarlimab for around six months in a clinical trial, and in the end, every one of them saw their tumours disappear.
Dostarlimab
Dostarlimab is a drug with laboratory-produced molecules that act as substitute antibodies in the human body.
Drug trial
Throughout the study, patients took Dostarlimab every three weeks for six months. Doctors then carried out a number of follow-up tests including physical exams, MRI scans and PET scans on the participants.
The study is published on Sunday (June 6) in the New England Journal of Medicine. The study is backed by drug maker GlaxoSmithKline.
READ | THIS country has become Covid free now after last patient recovered on June 6
Dr Luis A. Diaz J. of New York's Memorial Sloan Kettering Cancer Center said this was “the first time this has happened in the history of cancer”.
He told the publication, "I believe this is the first time this has happened in the history of cancer."
The patients involved in the clinical trial faced gruelling previous treatments to obliterate their cancer, such as chemotherapy, radiation and invasive surgery that could result in bowel, urinary and even sexual dysfunction.
The 18 patients went into the trial expecting to have to go through these as the next step. However, no further treatment was needed.
